Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Cardene in 0.83% sodium chloride in plastic container?

See the DrugPatentWatch profile for Cardene

Cardene (L‑carnitine) – 10 % IV Solution in 0.83 % Sodium Chloride (Plastic Vial)

Item Details
Active Ingredient L‑carnitine (100 mg mL⁻¹ – 10 % solution)
Vehicle 0.83 % Sodium Chloride (≈ 83 g L⁻¹) + water for injection
Container 10 mL polypropylene plastic vial, capped with a screw‑top lid
Appearance Clear, colourless to slightly pale yellow liquid
Labeling Manufacturer, batch number, expiry date, sterility statement, “Use at room temperature”
Typical Strength 1 g of L‑carnitine per 10 mL vial (100 mg mL⁻¹)
Isotonicity 0.83 % NaCl ≈ 83 g L⁻¹ (≈ 0.83 % w/v); slightly hypotonic compared with 0.9 % saline, but still considered “normotonic” for most IV uses

Why the 0.83 % NaCl?

  • Isotonicity: 0.83 % NaCl provides a near‑physiological osmolarity (≈ 290 mOsm kg⁻¹) which reduces the risk of hemolysis or phlebitis when the solution is administered IV.
  • Compatibility with L‑carnitine: L‑carnitine is soluble in a mildly hypotonic saline; 0.83 % is the formulation chosen by the manufacturer to maintain stability and avoid precipitation.

Indications & Typical Use

Condition Typical Dose (Adults) Administration
Inherited or acquired carnitine deficiency (e.g., primary carnitine deficiency, mitochondrial disorders) 0.5–1.0 g kg⁻¹ day⁻¹ (often divided) IV infusion 30–60 min; may be repeated daily or as needed
Severe metabolic acidosis or hypoglycemia in neonatal or pediatric patients 10–20 mg kg⁻¹ (single dose) Rapid IV push or infusion
Support in critical care (e.g., sepsis, cardiac failure) 30–50 mg kg⁻¹ (single or repeated) Short‑term infusion

Note: Exact dosing is individualized and should be guided by serum carnitine levels, clinical response, and the treating physician’s protocol.


Storage & Shelf Life

Condition Storage Shelf Life
Room Temperature (15–25 °C) Keep vial upright; avoid prolonged exposure to high heat ( >30 °C ) 3 years from manufacture if unopened; 7 days after opening if sealed properly
Refrigeration (≤ 8 °C) Only for certain formulations that require cold storage; not typical for Cardene 10 % Use within 48 h after refrigeration if re‑opened
Avoid light Store in the original opaque plastic container or in a dark place Same as above
  • Do not freeze – freezing can cause precipitation of the drug and compromise sterility.
  • Do not mix with other IV solutions unless the manufacturer or a compounding pharmacist confirms compatibility.

Handling & Administration Tips

  1. Check the vial: Inspect for particulate matter, cloudiness, or discoloration before use.
  2. Use a sterile needle/IV catheter.
  3. Dilute if needed: If the dose is large, the vial can be diluted with 0.9 % NaCl or 5 % dextrose to reach the desired volume; do so under aseptic conditions.
  4. Infuse slowly: Typical infusion rates range from 10 – 15 mL min⁻¹. Faster rates may increase the risk of irritation.
  5. Monitor: Watch for infusion reactions, especially in patients with a history of hypersensitivity to carnitine or sodium chloride.

Adverse Reactions

Symptom Frequency Notes
Gastro‑intestinal (nausea, vomiting, abdominal cramps) Rare Usually dose‑related; reduce dose if persistent
Allergic reactions (rash, urticaria, anaphylaxis) Very rare Use only if no other causes; pre‑medication not routine
Local irritation (phlebitis, extravasation) Low Ensure proper IV site and gentle infusion

Contraindications & Precautions

  • Hypersensitivity to L‑carnitine, sodium chloride, or any excipients.
  • Pregnancy & Lactation: Limited data; use only if clearly needed.
  • Renal impairment: L‑carnitine is primarily renally cleared; monitor serum levels if available.
  • Drug interactions: None specific, but avoid concurrent use of high‑dose calcium‑binding agents that may alter plasma carnitine.

Disposal

  • Unopened vials: Store at room temperature and discard at expiry.
  • Opened vials: Follow institutional sharps and hazardous waste protocols; do not reuse the vial or needle.
  • Residual solution: If any remains, it should be disposed of with other hazardous drug waste, not poured down the drain.

Quick Reference Checklist (for Clinicians)

  • [ ] Verify dosage and patient weight.
  • [ ] Inspect vial for integrity.
  • [ ] Dilute appropriately if large volume.
  • [ ] Infuse at recommended rate; monitor for reactions.
  • [ ] Document serum carnitine levels (if available) and clinical response.
  • [ ] Store remaining dose at recommended temperature; discard after 7 days.

Bottom line:
Cardene 10 % is a sterile, isotonic IV solution of L‑carnitine in a 0.83 % NaCl vehicle, packaged in a polypropylene vial that should be stored at room temperature, protected from light, and used within 7 days after opening. It’s employed primarily to correct carnitine deficiency and in certain acute metabolic emergencies, with a good safety profile when used per the indicated protocol.



Other Questions About Cardene :

Cardene vs cardizem? Cardene? Cardene in 0.86% sodium chloride in plastic container discount? Cardene in 0 86 sodium chloride in plastic container? Cardene cost? Cardene drip rate? Cardene drip use?